ADDITIVE SOLUTION PLATELET

Brand Owner Address Description
ATREUS TERUMO BCT, INC. 10811 W. Collins Avenue Lakewood CO 80215 [Additive solution for platelet; Anti-coagulant solution; Storage solution for red blood cells or white blood cells; Blood product products, namely, plasma, platelets, red blood cells, white blood cells.];Color is not claimed as a feature of the mark.;Medical apparatus for extracting one or more components from a composite liquid, namely, blood or buffy coat or bone marrow or umbilical cord blood, comprising an aqueous component, namely, plasma or an anticoagulant solution or a storage solution for blood cells, and one or more cellular components, namely, platelets, white blood cells or red blood cells or stem cells; Medical apparatus for extracting stem cells from bone marrow; Medical apparatus for extracting plasma, platelets, white blood cells or red blood cells from blood or a blood fraction; Blood washing apparatus; Medical equipment, namely, centrifuges for the separation of an aqueous component, namely, plasma or an anticoagulant solution or a storage solution for blood cells, and one or more cellular components, namely, platelets or white blood cells or red blood cells or stem cells, from a composite liquid, namely, blood or buffy coat or bone marrow or umbilical cord blood; Medical equipment, namely, centrifuges for the separation of plasma, platelets, white blood cells or red blood cells from blood or a blood fraction; [Medical equipment accessories for use with such apparatuses and centrifuges namely, filters for filtering a composite liquid, namely, blood or buffy coat, or a component of said composite liquid; Filter for filtering blood or a blood product; Medical equipment, namely, filters for removing white blood cells from blood or a blood product; Collection bag for receiving blood from a donor; Medical equipment, namely, separation bags for containing a composite liquid, namely, blood or buffy coat or bone marrow or umbilical cord blood, comprising an aqueous component, namely, plasma or an anticoagulant solution or a storage solution for blood cells, and one or more cellular components, namely, platelets or white blood cells or red blood cells or stem cells, to be separated;] Medical equipment, namely, circular separation bags for a composite liquid, namely, blood or buffy coat or bone marrow or umbilical cord blood; [Medical equipment, namely, Blood product bag for containing plasma, platelets, white blood cells or red blood cells;] Medical equipment, namely, separation sets comprising a separation bag for containing a composite liquid, namely, blood or buffy coat or bone marrow or umbilical cord blood connected to one or more bags for containing one or more components to be extracted from said composite liquid; [Bag for containing an additive solution for platelets; Medical equipment, namely, bags for containing an anti-coagulant solution; Medical equipment, namely, bags for containing a storage solution for red blood cells or white blood cells;] Medical equipment, namely, blood tubing sets comprising blood tubing lines, blood bags, blood access needles and solution bags;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides methods and compositions for reducing platelet activation, platelet aggregation and thrombosis. The invention further provides compositions and methods for treating or preventing diseases or disorders in which the pathology of the disease or disorder involves one or more of platelet activation, platelet aggregation and thrombus formation. The invention additionally relates to the use of protein palmitoylation inhibitors for the reduction of platelet activation, platelet aggregation and thrombosis, as well as to the use of protein palmitoylation as a target for the identification of inhibitors of platelet activation, platelet aggregation and thrombosis.